Literature DB >> 18682778

Management of kidney cancer: Canadian Kidney Cancer Forum Consensus Statement.

.   

Abstract

Entities:  

Year:  2008        PMID: 18682778      PMCID: PMC2494902     

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN: 1911-6470            Impact factor:   1.862


× No keyword cloud information.
  24 in total

Review 1.  Urologic approaches to metastatic renal cell carcinoma.

Authors:  G H Mickisch
Journal:  Onkologie       Date:  2001-04

2.  Long-term results of nephron sparing surgery for localized renal cell carcinoma: 10-year followup.

Authors:  A F Fergany; K S Hafez; A C Novick
Journal:  J Urol       Date:  2000-02       Impact factor: 7.450

3.  Radiofrequency ablation of renal cell carcinoma: part 2, Lessons learned with ablation of 100 tumors.

Authors:  Debra A Gervais; Ronald S Arellano; Francis J McGovern; W Scott McDougal; Peter R Mueller
Journal:  AJR Am J Roentgenol       Date:  2005-07       Impact factor: 3.959

4.  Radical nephrectomy for renal cell carcinoma: Is adrenalectomy necessary?

Authors:  R von Knobloch; F Seseke; H Riedmiller; H J Gröne; E M Walthers; T Kälble
Journal:  Eur Urol       Date:  1999-10       Impact factor: 20.096

5.  The number of lymph nodes examined and staging accuracy in renal cell carcinoma.

Authors:  C Terrone; S Guercio; S De Luca; M Poggio; E Castelli; C Scoffone; R Tarabuzzi; R M Scarpa; D Fontana; S Rocca Rossetti
Journal:  BJU Int       Date:  2003-01       Impact factor: 5.588

6.  Antitumor effects of sunitinib or sorafenib in patients with metastatic renal cell carcinoma who received prior antiangiogenic therapy.

Authors:  Ila Tamaskar; Jorge A Garcia; Paul Elson; Laura Wood; Tarek Mekhail; Robert Dreicer; Brian I Rini; Ronald M Bukowski
Journal:  J Urol       Date:  2007-11-12       Impact factor: 7.450

7.  Renal cell carcinoma with retroperitoneal lymph nodes. Impact on survival and benefits of immunotherapy.

Authors:  Allan J Pantuck; Amnon Zisman; Frederich Dorey; Debby H Chao; Ken-Ryu Han; Jonathan Said; Barbara Gitlitz; Arie S Belldegrun; Robert A Figlin
Journal:  Cancer       Date:  2003-06-15       Impact factor: 6.860

8.  Cytoreductive nephrectomy in patients with metastatic renal cancer: a combined analysis.

Authors:  Robert C Flanigan; G Mickisch; Richard Sylvester; Cathy Tangen; H Van Poppel; E David Crawford
Journal:  J Urol       Date:  2004-03       Impact factor: 7.450

9.  Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy.

Authors:  Bradley C Leibovich; Michael L Blute; John C Cheville; Christine M Lohse; Amy L Weaver; Horst Zincke
Journal:  J Urol       Date:  2004-03       Impact factor: 7.450

10.  Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma.

Authors:  Gary Hudes; Michael Carducci; Piotr Tomczak; Janice Dutcher; Robert Figlin; Anil Kapoor; Elzbieta Staroslawska; Jeffrey Sosman; David McDermott; István Bodrogi; Zoran Kovacevic; Vladimir Lesovoy; Ingo G H Schmidt-Wolf; Olga Barbarash; Erhan Gokmen; Timothy O'Toole; Stephanie Lustgarten; Laurence Moore; Robert J Motzer
Journal:  N Engl J Med       Date:  2007-05-31       Impact factor: 91.245

View more
  11 in total

Review 1.  Treatment of metastatic renal cell carcinoma.

Authors:  Maxine Sun; Giovanni Lughezzani; Paul Perrotte; Pierre I Karakiewicz
Journal:  Nat Rev Urol       Date:  2010-05-11       Impact factor: 14.432

2.  Management of kidney cancer: canadian kidney cancer forum consensus update 2011.

Authors:  Mas Jewett; A Finelli; C Kollmannsberger; L Wood; L Legere; J Basiuk; C Canil; D Heng; N Reaume; S Tanguay; M Atkins; G Bjarnason; J Dancey; M Evans; N Fleshner; M Haider; A Kapoor; R Uzzo; D Maskens; D Soulieres; G Yousef; N Basappa; N Bendali; P Black; N Blais; I Cagiannos; M Care; R Chow; H Chung; P Czaykowski; D Derosa; K Durrant; S Ellard; G Farquharson; C Filion-Brulotte; J Gingerich; L Godbout; R Grant; W Hamilton; W Kassouf; G Kurban; K Lane; Jb Lattouf; D Lau; M Leveridge; J McCarthy; R Moore; S North; P O'brien; E Pituskin; P Racine; R Rendon; A So; S Sridhar; K Stubbs; Z Su; L Taylor; T Udall; P Venner; W Vogel; S Yap; P Yau; M Cooper; N Giroux; D Miron; D Mosher; K Ross; J Willacy
Journal:  Can Urol Assoc J       Date:  2012-02       Impact factor: 1.862

3. 

Authors: 
Journal:  Can Urol Assoc J       Date:  2009-06       Impact factor: 1.862

4.  Recent developments in kidney cancer.

Authors:  Michael J Leveridge; Michael A S Jewett
Journal:  Can Urol Assoc J       Date:  2011-06       Impact factor: 1.862

5.  Management of Advanced Kidney Cancer: Kidney Cancer Research Network of Canada (KCRNC) consensus update 2019.

Authors:  Sebastien J Hotte; Anil Kapoor; Naveen S Basappa; Georg Bjarnason; Christina Canil; Henry J Conter; Piotr Czaykowski; Jeffrey Graham; Samantha Gray; Daniel Y C Heng; Pierre I Karakiewicz; Christian Kollmannsberger; Aly-Khan A Lalani; Scott A North; François Patenaude; Denis Soulières; Phillippe Violette; Eric Winquist; Lori A Wood; Shaan Dudani; Ranjena Maloni; M Neil Reaume
Journal:  Can Urol Assoc J       Date:  2019-10       Impact factor: 1.862

6.  Management of advanced kidney cancer: Canadian Kidney Cancer Forum consensus update.

Authors:  Scott A North; Naveen Basappa; Joan Basiuk; Georg Bjarnason; Rodney Breau; Christina Canil; Daniel Heng; Michael A S Jewett; Anil Kapoor; Christian Kollmannsberger; Kylea Potvin; M Neil Reaume; J Dean Ruether; Peter Venner; Lori Wood
Journal:  Can Urol Assoc J       Date:  2015 May-Jun       Impact factor: 1.862

7.  Laparoscopic partial nephrectomy: the University of Saskatchewan (Regina division) experience.

Authors:  Andrew Tse; Russel Knaus; Edward Tse
Journal:  Can Urol Assoc J       Date:  2009-04       Impact factor: 1.862

8.  Management of advanced kidney cancer: Canadian Kidney Cancer Forum (CKCF) consensus update 2017.

Authors:  M Neil Reaume; Naveen S Basappa; Lori Wood; Anil Kapoor; Georg A Bjarnason; Normand Blais; Rodney H Breau; Christina Canil; Patrick Cheung; Henry J Conter; Sebastien J Hotte; Claudio Jeldres; Michael A S Jewett; Pierre I Karakiewicz; Christian Kollmannsberger; Francois Patenaude; Alan So; Denis Soulières; Peter Venner; Phillippe Violette; Pawel Zalewski; Heather Chappell; Scott A North
Journal:  Can Urol Assoc J       Date:  2017-10       Impact factor: 1.862

9.  Management of advanced kidney cancer: Canadian Kidney Cancer Forum 2013 Consensus Update: Canadian Kidney Cancer Forum 2013.

Authors:  Scott North; Naveen Basappa; Georg Bjarnason; Normand Blais; Christina Canil; Daniel Heng; Jennifer Knox; Neil Reaume; Dean Ruether; Denis Soulières; Pawel Zalewski; Peter Black; Rodney H Breau; Rodney Breau; Michael Jewett; Anil Kapoor; Jean-Baptiste Lattouf; Ronald Moore; Ricardo Rendon; Gerald Todd; Edith Pituskin; Craig Gedye; Lori Wood
Journal:  Can Urol Assoc J       Date:  2013 Jul-Aug       Impact factor: 1.862

10.  Review of guidelines on the treatment of metastatic renal cell carcinoma.

Authors:  D Soulières
Journal:  Curr Oncol       Date:  2009-05       Impact factor: 3.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.